Financials
- Market Capitalization 334.14 M
- Employee 161
- Founded 2018
- CEO N/A
- Website www.lyell.com
- Headquarter Delaware, United States
- FIGI BBG00RNXFN14
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.47
市销率
11.12 K
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3228 | FATE Fate Therapeutics, Inc. - Common Stock | 2.98 USD | -0.33% | +1.71% | +46.80% | +161.40% | 347.35 M USD | ||
| 3236 | INDP Indaptus Therapeutics, Inc. - Common Stock | 2.98 USD | +13.31% | +23.14% | -21.37% | +56.84% | 337.46 M USD | ||
| 3244 | IMRX Immuneering Corporation - Class A Common Stock | 5.18 USD | -0.58% | -6.33% | +23.63% | +27.59% | 335.13 M USD | ||
| 3249 | ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.78 USD | +0.21% | -1.65% | +27.13% | +254.07% | 340.27 M USD |